Clinical Solutions appoints three C-suite executives to lead product, finance, and talent functions amid strong first-half ...

WCG's Activation Intelligence targets clinical trial rework by catching document conflicts before activation, saving sites ...

ASP-1929 + Pembrolizumab achieved 28.2-month median OS in recurrent/metastatic HNSCC, with 35% alive at four years in Phase ...

A Nature Neuroscience study separates psilocybin's neuroplastic effects from its hallucinogenic ones, and it should reshape ...

MA beneficiaries received kidney transplants at nearly half the rate of traditional Medicare patients post-Cures Act, a ...

Novartis's pelacarsen hit its Lp(a) target in 8,323 patients but missed the cardiovascular endpoint entirely, exposing a $6B ...

YPrime names Greg Wellbrock Chief Data and AI Officer to lead unified data and AI strategy across its clinical trial ...

Arcus Biosciences has $694M in cash to advance its pipeline through pivotal trials, including the Phase 3 PRISM-1 study of ...

Fifth Circuit vacates class certification in Filana Therapeutics securities case, removing litigation overhang as company ...

FDA clears Fresenius multiFiltratePRO for regional citrate anticoagulation in acute kidney injury, with integrated pumps and ...

Veeva launches flat-rate AI pricing and Falcon agentic tools for clinical trials. Explore simplified pricing and platform ...

FDA AI Guidance requires clinical trial sponsors to validate algorithms before submission, shifting documentation and testing ...